A case-control study of risk factors for colorectal cancer in an African population.
Journal
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)
ISSN: 1473-5709
Titre abrégé: Eur J Cancer Prev
Pays: England
ID NLM: 9300837
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
pubmed:
13
4
2018
medline:
2
8
2019
entrez:
13
4
2018
Statut:
ppublish
Résumé
The interplay between hereditary and environmental factors in the causation of colorectal cancer in sub-Saharan Africa is poorly understood. We carried out a community based case-control study to identify the risk factors associated with colorectal cancer in Zimbabwe. We recruited 101 cases of colorectal cancer and 202 controls, matched for age, sex and domicile. Potential risk factors including family history, socioeconomic status, urbanization, diabetes mellitus and previous schistosomiasis were evaluated. Conditional logistic regression was used to estimate the odds ratios associated with the different factors. Cases were more likely to have a tertiary education (32.7 vs. 13.4%, P<0.001) and a higher income (18.8 vs. 6.9%, P=0.002). After multivariate analysis, diabetes mellitus [odds ratio (OR): 5.3; 95% confidence interval (CI): 1.4-19.9; P=0.012], previous urban domicile (OR: 2.8; 95% CI: 1.0-7.8; P=0.042), previous schistosomiasis (OR: 2.4; 95% CI: 1.4-4.2; P=0.001) and cancer in a first-degree relative (OR: 2.4; 95% CI: 1.2-4.8; P=0.018) were associated independently with colorectal cancer. Our findings suggest that family history, diabetes mellitus, previous schistosomiasis and approximation to a western lifestyle are the predominant associations with colorectal cancer in Africans. This offers opportunities for targeted prevention and hypothesis-driven research into the aetiology of colorectal cancer in this population.
Identifiants
pubmed: 29649072
doi: 10.1097/CEJ.0000000000000439
pmc: PMC6076991
mid: EMS75585
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Pagination
145-150Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Références
PLoS Negl Trop Dis. 2014 Aug 14;8(8):e3014
pubmed: 25121489
Br J Cancer. 2001 Sep 28;85(7):1037-46
pubmed: 11592777
Am J Gastroenterol. 2005 Mar;100(3):515-23; discussion 514
pubmed: 15743345
Cancer Epidemiol Biomarkers Prev. 1996 Dec;5(12):1013-5
pubmed: 8959325
Lancet. 2008 Feb 16;371(9612):569-78
pubmed: 18280327
Int J Colorectal Dis. 2007 Feb;22(2):175-81
pubmed: 16786317
IARC Monogr Eval Carcinog Risks Hum. 1994;61:1-241
pubmed: 7715068
Am J Gastroenterol. 2011 Nov;106(11):1911-21; quiz 1922
pubmed: 21912438
Int J Cancer. 2013 Aug 1;133(3):721-9
pubmed: 23364833
PLoS One. 2013 Sep 12;8(9):e74616
pubmed: 24069323
Lancet Gastroenterol Hepatol. 2017 May;2(5):377-383
pubmed: 28397702
Endocrinology. 1997 May;138(5):2211-4
pubmed: 9112423
World J Surg Oncol. 2013 Apr 18;11:88
pubmed: 23597032
Nutr Cancer. 1997;27(3):316-20
pubmed: 9101563
N Engl J Med. 2000 Jul 13;343(2):78-85
pubmed: 10891514
J Natl Cancer Inst. 2004 Feb 18;96(4):261-8
pubmed: 14970275
Nutrients. 2011 Apr;3(4):429-41
pubmed: 22254104
Cancer Epidemiol Biomarkers Prev. 2014 Jun;23(6):953-66
pubmed: 24700176
Diabetes Res Clin Pract. 2016 Aug;118:1-11
pubmed: 27485851
Int J Epidemiol. 2011 Aug;40(4):885-901
pubmed: 21527446
Eur J Cancer. 2013 Apr;49(6):1374-403
pubmed: 23485231
Br J Cancer. 2009 Feb 24;100(4):611-6
pubmed: 19209175
Lancet Oncol. 2015 Dec;16(16):1599-600
pubmed: 26514947
CA Cancer J Clin. 2017 Jan;67(1):7-30
pubmed: 28055103
Gastroenterology. 1992 Apr;102(4 Pt 1):1101-8
pubmed: 1312970
S Afr Med J. 2009 Feb;99(2):103-6
pubmed: 19418671
Cancer Epidemiol. 2016 Oct;44:96-100
pubmed: 27541963